Reify Health
Founded Year
2012Stage
Series D | AliveTotal Raised
$483.64MValuation
$0000Last Raised
$220M | 2 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-92 points in the past 30 days
About Reify Health
Reify Health is a company focused on improving the clinical trial process within the healthcare industry. The company offers cloud-based software that accelerates patient enrollment in clinical trials, thereby facilitating the development of new therapies. Reify Health primarily serves the healthcare and biopharma industries. The company was formerly known as ZeroSum Health. It was founded in 2012 and is based in Boston, Massachusetts.
Loading...
ESPs containing Reify Health
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The decentralized clinical trials platforms market specifically encompasses software and technology solutions designed to facilitate and manage remote clinical trials. These platforms integrate various components such as telemedicine, mobile health applications, and wearable device data collection to enable trial activities without frequent site visits. By streamlining remote participation, these …
Reify Health named as Highflier among 15 other companies, including ObvioHealth, Huma, and Medable.
Loading...
Research containing Reify Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Reify Health in 5 CB Insights research briefs, most recently on Aug 21, 2024.
Expert Collections containing Reify Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Reify Health is included in 3 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,244 items
Digital Health
11,060 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Digital Health 50
150 items
The winners of the third annual CB Insights Digital Health 150.
Reify Health Patents
Reify Health has filed 2 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/6/2010 | 4/7/2015 | Fractals, Dynamical systems, Chemical processes, Systems theory, Robotics | Grant |
Application Date | 1/6/2010 |
|---|---|
Grant Date | 4/7/2015 |
Title | |
Related Topics | Fractals, Dynamical systems, Chemical processes, Systems theory, Robotics |
Status | Grant |
Latest Reify Health News
Sep 18, 2023
Sierra Ventures recently announced the closing of their 13th fund at $265 million, exceeding its target. And the firm has a disciplined model of right-sized funds to focus on being an early investor in the best B2B companies across North America at the seed and Series A stages. The firm has also generated top-performing funds by being the first investor in unicorns like Reify Health (Vertical SaaS) in Boston, Phenom (Enterprise Applications) in Philadelphia, and Astronomer (Infrastructure Software) in Cincinnati. Since 2012 – under the leadership of current Managing Partners Mark Fernandes, Tim Guleri, and Ben Yu – Sierra has raised three top-performing funds, while also thoughtfully growing the fund size to match their focus on the Seed and Series A stages. And Fund XIII will continue this strategy of finding the best B2B companies across the country and helping entrepreneurs scale their businesses with resources across product and go-to-market, executive recruiting, and fundraising. Plus, Sierra’s CXO Advisory Board, now in its 18th year, provided invaluable advice from over 75 F1000 technology executives to portfolio companies. Over the last 18 years, Sierra built an industry leading CXO board of over 75 Fortune 1000 CIOs, CTOs, CMOs, and CISOs. KEY QUOTES: “We are passionate about partnering with entrepreneurs with a vision to build enduring companies and helping them transform their ideas into successful businesses. The Sierra team takes a hands-on approach, rolling up our sleeves to work alongside founders, sharing our insights, and leveraging our extensive network to open doors that accelerate their development and market presence.” – Tim Guleri “Sierra’s CXO board serves as a compass for B2B startup founders, guiding them through the often-challenging landscape of enterprise selling. This council of experienced industry leaders not only offers key insights into technology gaps and strategic feedback to portfolio founders but provides a platform for meaningful connections.” – Mark Fernandes “The Sierra team has been an outstanding partner since leading our Series A, and they really appreciate how challenging the role of an early-stage founder is. They bring a wealth of enterprise software experience and a strong network to our team and are always willing to help.” – Ralph Passarella, Co-Founder & CEO of Reify Health “In a world where fund size might often be viewed as a measure of success, Sierra has taken a thoughtful approach to growing the size of its funds as well as maintaining discipline about the initial valuation of our investments. Both factors have contributed to the strong performance of our current funds, and we plan to continue that model.” – Ben Yu
Reify Health Frequently Asked Questions (FAQ)
When was Reify Health founded?
Reify Health was founded in 2012.
Where is Reify Health's headquarters?
Reify Health's headquarters is located at 33 Arch Street, Boston.
What is Reify Health's latest funding round?
Reify Health's latest funding round is Series D.
How much did Reify Health raise?
Reify Health raised a total of $483.64M.
Who are the investors of Reify Health?
Investors of Reify Health include Battery Ventures, Adams Street Partners, Coatue, ICONIQ Growth, Altimeter Capital and 8 more.
Who are Reify Health's competitors?
Competitors of Reify Health include ObvioHealth, Science 37, Pentavere Research Group, Curebase, Clara Health and 7 more.
Loading...
Compare Reify Health to Competitors
Medable specializes in providing digital clinical trial software solutions within the healthcare and pharmaceutical sectors. The company offers a comprehensive platform that facilitates the management of clinical trials, including tools for remote data collection, electronic consent (eConsent), patient-reported outcomes (ePRO), and clinical outcome assessments (eCOA), all designed to streamline the trial process and enhance data quality. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
Curebase provides a range of software tools designed for clinical trial recruitment, consent, and data collection processes. Curebase primarily serves the clinical research industry, including CROs, research sites, and study participants. The company was founded in 2017 and is based in San Francisco, California.
THREAD is a company that focuses on providing a decentralized clinical trial platform in the healthcare and life sciences industry. The company offers a platform and supporting services that enable biopharma, CROs, and life science organizations to remotely capture data from participants and sites during, in-between, and in lieu of in-clinic visits. The platform includes features such as electronic consent (eConsent), electronic clinical outcome assessment (eCOA), sensors, reminders, and telehealth virtual visits. It was founded in 2005 and is based in Tustin, California.
Hawthorne Effect specializes in providing mobile, tech-driven solutions for clinical trials within the healthcare sector. The company offers a platform that facilitates mobile clinical trial visits, enhances patient access, and ensures high-quality data collection through a network of healthcare professionals. Hawthorne Effect primarily serves the biopharma, medtech, and healthcare industries by improving clinical trial efficiency, data quality, and patient diversity. It was founded in 2015 and is based in Lafayette, California.
Formation Bio is a tech-driven, AI-native pharmaceutical company focused on drug development. The company specializes in acquiring and developing clinical-stage drugs more efficiently by leveraging a proprietary technology platform that incorporates artificial intelligence. Formation Bio primarily serves the pharmaceutical industry by expediting the drug development process for various therapeutic areas. It was formerly known as TrialSpark. It was founded in 2013 and is based in New York, New York.
BloqCube is a software company specializing in decentralized clinical trial management and financial systems. The company offers an integrated Clinical Trial Management & Financial System (CTMFS) platform designed to accelerate Decentralized Clinical Trials (DCT) by providing a secure, transparent, and efficient way to manage trials and handle financial transactions. BloqCube primarily serves the healthcare and pharmaceutical sectors by streamlining clinical trial processes and financial management. It was founded in 2017 and is based in Piscataway, New Jersey.
Loading...